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A B S T R A C T
There is considerable interest in dexamethasone, a synthetic glucocorticosteroid drug, and a number of reports
detailing the controlled release of dexamethasone from polypyrrole have been published. However, polypyrrole-
doped with dexamethasone is poorly characterised. In this study, polypyrrole doped with dexamethasone was
formed at relatively low applied potentials of 0.70 V or 0.80 V vs SCE by carrying out the electropolymerisation
on an initial pre-layer of polypyrrole. These polymers displayed electroactive behaviour with a dexamethasone
doping level of 0.30 ± 0.03 and using impedance measurements the charge-transfer resistance was computed as
400Ω. Mixed ion transport was observed. In addition to the release of dexamethasone, hydrated sodium cations
were incorporated to maintain charge neutrality on reduction of the polymer. Approximately 200 μg cm−2 of
dexamethasone was released following 60min on reduction of the polymer at −0.90 V vs SCE. It was possible to
re-use the polymer to release the drug by repeated oxidation and reduction steps, where dexamethasone was
incorporated during oxidation and released on reduction. During these events, sodium was accumulated within
the polymer matrix and this high salt content accompanied with swelling and de-swelling events gave rise to the
development of cracks in the polymer matrix.
1. Introduction
In recent years there has been considerable interest in conducting
polymers as they possess a range of interesting properties and potential
applications. Furthermore, they are easily formed and fabricated using
electropolymerisation with a suitable dopant or by chemical poly-
merisation using a dopant and an oxidising agent. In particular, poly-
pyrrole has been identified as a biomaterial with applications in tissue
engineering, as biosensors and in drug delivery [1,2]. In terms of drug
delivery, polypyrrole has been used to deliver anionic, cationic and
neutral drug molecules [2–13]. The release of the drug molecule is
achieved by electrochemically switching the polymer between its re-
duced and oxidised states. For anionic drugs, the drug molecule is in-
corporated as a dopant during the electropolymerisation of the
monomer and it is then released on reduction of the polymer. Large
immobile dopants are used to bind cationic drugs within the polymer
matrix. In this case, the cationic drug is released on oxidation of the
polymer. Dexamethasone is one drug molecule that has received a lot of
interest [9–13]. This is no surprise, as it is a synthetic glucocorticos-
teroid and is used in several treatments including the reduction of in-
flammation [14]. The prodrug, dexamethasone 21-phosphate disodium
salt, is anionic and it can be incorporated as an anionic dopant within
the polymer and released on reduction of the polymer film.
However, dexamethasone is large and its solubility in aqueous so-
lutions is relatively low, limiting the concentration that can be used
during the electropolymerisation of pyrrole. As a result, relatively high
applied potentials or high applied current densities are normally used
to promote the growth of the dexamethasone doped polypyrrole. For
example, Seyfoddin et al. [12] used an applied current density of
2mA cm−2, while Zhang et al. [13] used current densities between 0.5
and 1.5mA cm−2. Sirivisoot et al. [15] used cyclic voltammetry and
cycled the potential to 1.1 V vs Ag/AgCl to form the polymer, while
Wadhwa et al. [16] formed the polymer at 1.8 V and subsequently re-
leased the dexamethasone by cycling the polymer between −0.80 V
and 1.4 V vs SCE. Although many of these conditions will give rise to
more open and porous polymers, that are capable of delivering higher
amounts of drugs, they are also likely to give rise to some degree of
over-oxidation of the polypyrrole and as this is an irreversible reaction,
it will limit the redox switching of the polymer. Furthermore, the focus
of these publications is on the release of dexamethasone from the
polymer matrix and little attention is devoted to the properties of the
PPyDex polymer system.
The aim of this study is to gain information on the properties of
PPyDex, including its conducting properties, cation and anion exchange
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properties, and doping levels. In order to study these electrochemical
properties, the PPyDex is formed under conditions that minimise the
over-oxidation of the polymer matrix and the influence of these elec-
tropolymerisation conditions on the release of dexamethasone is briefly
described.
2. Experimental method
The chemicals used throughout this study were purchased from
Sigma-Aldrich (Analar grade reagents). Pyrrole was vacuum-distilled
and stored in the dark at−20 °C prior to use. A standard three electrode
cell was used in all experiments. A high surface area platinum wire
served as the counter electrode and a saturated calomel (SCE) electrode
was used as the reference electrode. A platinum disc electrode (99.99%
purity) with a surface area of 0.125 cm2 was employed as the working
electrode (the surface area of the platinum substrate, and not the
polymer, was used to express the release in μg cm−2). The platinum
electrode was fabricated by embedding a platinum rod in a Teflon
holder, which was filled with epoxy resin and a copper wire was
threaded into the base of the metal sample for electrical contact. The
exposed surface was polished to a mirror finish using successively
smaller sizes of diamond paste to a final size of 1 μm on a microcloth
(Buehler). The surface of the platinum electrode was then rinsed with
distilled water, cleaned in an ultrasonic bath to remove any polishing
residues and finally dried in a stream of air.
Cyclic voltammetry and potentiostatic current-time plots were car-
ried out using a Solartron (Model SI 1287) potentiostat, while im-
pedance measurements were performed with a Solartron frequency
response analyser (Model SI 1255) in conjunction with an electro-
chemical interface (Solarton Model SI 1287). The EQCM experiments
were carried out on a CHi440 EQCM system. The polymers were de-
posited onto polished Au quartz crystal electrodes (Cambria Scientific)
with an exposed surface area of 0.203 cm2. The electrochemical cell
consisted of a specially made Teflon holder in which the crystal was
placed between two o-rings, a platinum wire counter and a custom-
made Ag|AgCl reference electrode. The Sauerbrey equation, Eq. (1),
was used to convert the oscillation frequency to the mass at the crystal.
In this equation, Δf represents the observed frequency change, Cf is the
sensitivity of the crystal, which was found experimentally to be 7.9897
× 108 Hz cm2 g−1, and Δm represents the mass change. Thin polymer
films were deposited to minimise viscoelastic effects, as this analysis is
only valid for thin, uniform and rigid films on the crystal [17].
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The surface morphology of the polymer samples was obtained using
a Hitachi SEM. The samples were sputter coated with gold using an
Emitech K550x gold sputter coater prior to analysis.
The release of dexamethasone from the polypyrrole matrix was
monitored using UV–visible spectroscopy (Cary 50 UV–visible spec-
trometer). Prior to the release experiments, the polymer was thoroughly
washed in water, then immersed in distilled water and polarised at
0.50 V vs SCE for a 15min period. The solution was stirred continuously
throughout this period to aid diffusion of dexamethasone that was
trapped within the polymer matrix. All release studies were repeated
three times and the standard error was calculated and is represented as
error bars on the release plots.
3. Results and discussion
The structure of dexamethasone is shown in Fig. 1, as the dex-
amethasone 21-phosphate disodium salt. The presence of the phosphate
group on the dexamethasone steroid ring structure imparts a negative
charge to the drug, making it suitable for incorporation as a dopant in
polypyrrole. Although this salt is a divalent anion at pH 8.0, Dex-PO32−
(Dex2−) which is the natural pH of the solution when dexamethasone is
dissolved, the pKa values of approximately 1.18 and 7.20, will give rise
to the formation of Dex-HPO3− (Dex−), as the solution becomes acid-
ified during the electropolymerisation process. This will give rise to a
monovalent anion, Dex−, as the dopant. Although dexamethasone is a
large dopant with a molecular weight of 470 gmol−1 (for Dex2−) it has
been successfully incorporated into polypyrrole. However, as outlined
earlier, high applied potentials [15,16] or galvanostatic conditions at
relatively high currents [12,13] are normally used. These approaches
are likely to give rise to some over-oxidation of the polypyrrole matrix,
reducing its redox activity.
3.1. Electropolymerisation and formation of PPyDex
In an attempt to form the polypyrrole film at lower applied poten-
tials, the electropolymerisation of pyrrole in 0.05mol dm−3 Dex and
0.2 mol dm−3 pyrrole at applied potentials between 0.70 V and 0.90 V
vs SCE was studied. Although some polymer was nucleated and formed
at the lower potentials, the current increased slowly over the timeframe
of the experiment, and only patches of the polymer was observed at the
electrode. This inefficient and low rate of electropolymerisation may be
connected to the large size of dexamethasone and its large ring struc-
ture with poor flexibility, with no rotation of the molecule possible
within this ring structure. Furthermore, the pH of the dexamethasone-
containing solution, is relatively high at 8.2. It is well known that the
rate of electropolymerisation decreases as the pH is increased and it is
difficult to electropolymerise pyrrole at pH values higher than 8.0
[18,19]. When the applied potential was increased to 0.90 V vs SCE, the
polymer, PPyDex, formed rapidly. A representative current-time plot is
shown in Fig. 2. There is a rapid increase in the current over the initial
180 s, then a steady state current, or plateau, is observed, indicating a
constant rate of electropolymerisation. However, these high rates of
electropolymerisation gave rise to poor reproducibility and different
amounts of polymer were deposited. In order to control the rate of
electropolymerisation and maintain the conducting and redox activity
of the polymer, a two-step approach was used. This involved the for-
mation of the polymer at an initially high potential of 0.90 V vs SCE to
nucleate the polymer at the surface, followed by a slower and more
controlled rate of electropolymerisation. In Fig. 3, data are shown, as
charge-time plots, for the formation of PPyDex at lower applied po-
tentials at PPyDex or PPyCl modified electrodes. In Fig. 3(a) a potential
of 0.90 V vs SCE was applied until a charge of 0.8 C cm−2 was reached
and then the remaining polymer growth was carried out at 0.80 V vs
SCE until a charge of 2.0 C cm−2, giving a total charge of 2.8 C cm−2.
For the initial step at 0.90 V vs SCE, the slopes of the charge-time plots
(linear region) varied from 3.3× 10−3 to 4.8× 10−3 C cm−2 s−1 while
Fig. 1. Chemical structure of dexamethasone (shown as the sodium salt).
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the slopes ranged from 3.9×10−3 to 4.1× 10−3 C cm−2 s−1 in the
second step. These data show that once the initial deposition of PPyDex
is achieved, the rate of electropolymerisation of pyrrole at 0.80 V vs
SCE is considerably more reproducible and occurs at a rate which is
similar to that observed initially at 0.90 V vs SCE. For the data shown in
Fig. 3(b), the PPyCl film was formed at 0.60 V vs SCE to reach a charge
of 0.16 C cm−2, and then the PPyDex film was formed at 0.80 V or
0.70 V until a total charge of 2.8 C cm−2 was achieved. Again, it is
clearly evident that PPyDex can be formed at much lower applied po-
tentials once an initial layer of polypyrrole is deposited at the surface.
The thickness of the polymers was estimated as 5.8 μm using Faraday's
Law, Eq. (2), where M is the molar mass of pyrrole, q is the charge, A is
the surface area of the electrode, z is the number of electrons trans-
ferred, F is the Faraday constant and ρ is the density of polypyrrole,
taken as 1.5 g cm−3. However, as the dopant is large, the thickness will
be somewhat higher than this theoretical estimate.
=x
qM
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3.2. Doping level of PPyDex
EQCM was used to study the initial steps in the electropolymerisa-
tion and to obtain information on the doping level of the PPyDex film.
The PPyDex was grown to a charge of 3.5× 10−2 C by applying a
constant potential of 0.90 V vs Ag/AgCl. In Fig. 4, the frequency-charge
and mass-charge plots are shown. It can be seen that the mass increases
and the frequency decreases sharply once a charge of 1.5× 10−2 C is
reached. This is very different to that observed on forming PPyCl,
shown in the inset in Fig. 4. Once this charge is reached, the mass-to-
charge ratio is approximately 1.2×10−3 g C−1, while a much lower
ratio of 3.6× 10−4 g C−1 is obtained during the initial stage of de-
position. This may be related to soluble polymer oligomers that do not
deposit onto the electrode, or possibly the adsorption of dexamethasone
at the electrode surface. Indeed, as evident from the cyclic voltammo-
grams shown in Fig. 5, the presence of dexamethasone gives rise to a
reduction in the peaks associated with hydrogen ion adsorption and
there is a considerable shift in the peak potential for the reduction of
platinum oxide/hydroxide, from approximately −0.50 V to −0.80 V vs
SCE. This is consistent with the adsorption of dexamethasone, which
may initially inhibit the electropolymerisation process.
The EQCM measurements were used with Eq. (3), a derivation of
Faraday's law, to estimate the doping levels. In these equations, M is the
total mass of the deposited polymer, Q is the charge reached, Mm is the
mass of the monomer, Mdop is the mass of the dopant, x is the doping
level (x≤ 0.33) and F is Faraday's constant. However, this equation
does not take into account solvent participation, or the adsorption of
dexamethasone, and assumes a 100% efficiency in the electro-
polymerisation of the monomer. Using the slope of the linear mass-
charge data, for PPyCl (shown in the inset), the doping level was cal-
culated as 0.33, in good agreement with several previous studies
[20,21].
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However, the mass-charge data for PPyDex does not have a simple
linear relationship. The initial mass-charge slope of 3.6× 10−4 g C−1
indicates inefficient electropolymerisation and the mass-charge slope at
the later times is more representative of the bulk polymer deposition.
The initial doping level was estimated as 0.025 ± 0.005, while the
doping level associated with the second step was considerably higher at
0.30 ± 0.03. This results in a doping level of about 0.30, once the
initial growth period has elapsed.
3.3. Conducting and mixed ion exchange properties
The redox properties of PPyDex were examined using cyclic cyclic
voltammetry coupled with EQCM. These data are shown in Fig. 6 and
were recorded in an acidified pH 3.0, 0.1mol dm−3 NaCl solution.
During the reduction scan, an increase in mass occurs, corresponding to
the insertion of sodium cations, or sodium cations with water mole-
cules. Although there may be some dopant anions released from the
polymer during this period, the net mass change shows high amounts of
sodium intake. This increase in mass begins at approximately 0.0 V vs
Ag/AgCl, and continues to increase, reaching a maximum rate at
−0.40 V vs Ag/AgCl, close to the potentials where the reduction peak is
observed in the voltammogram. During the reverse cycle, the mass
decreases corresponding to the ejection of the cations. A further in-
crease in mass is seen between approximately 0.40 V and 0.80 V vs Ag/
AgCl and this is connected to the uptake of chloride anions from the
supporting electrolyte. These data show that the polymer displays
mixed ion exchange behaviour. In addition to the uptake of Na+ and
the release of Cl− or Dex− from the polymer film, solvent/water mo-
lecules are also transferred. It is also clear that the rate of Na+ uptake is
higher that its rate of release, as evident from the slopes of the mass
data, Fig. 6. This may indicate the incorporation of a large amount of
water with the Na+. Alternatively, it may point to a slower release of
Na+ due to electrostatic interactions with the anionic dexamethasone,
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Fig. 2. Current-time plot recorded during the deposition of PPyDex at 0.90 V vs
SCE in 0.05mol dm−3 Dex and 0.20mol dm−3 pyrrole.
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Fig. 3. Charge-time plots for the formation of PPyDex in
0.05mol dm−3 NaDex and 0.20mol dm−3 pyrrole (left) at a
constant potential of 0.90 V vs SCE on platinum and
0.80 V vs SCE on a PPyDex film and (right) formation
of PPyDex on a film of PPyCl at 0.80 V vs SCE and at
0.70 V vs SCE.
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Dex−, within the polymer matrix or a complex relationship between the
release of Na+ and the uptake of Cl−. This indicates that dex-
amethasone behaves like a medium-to-large sized anion and displays
mixed ion exchange behaviour. It is well known that the exchange
properties of polypyrrole depend on the size, type and valence of the
dopant and when small dopants, such as chloride, are used, the charge
neutrality on reduction of the polymer is achieved by the expulsion of
the anionic dopant [22,23]. When dopants such as polystyrenesulfonate
or dodecylbenzenesulfonate, are incorporated into polypyrrole, then
the polymer acts like a cation exchanger and cations are transferred
from the solution to the polymer matrix to maintain charge balance on
reduction as the large dopants are immobile and not released [24].
It is also evident from Fig. 6 that PPyDex is conducting and these
conducting properties were further explored using electrochemical
impedance data. These data were recorded as a function of time over
8 h in a 0.1 mol dm−3 NaCl solution. Representative data recorded at
the open-circuit potential (0.24 V vs SCE) and at −0.90 V vs SCE are
shown as Bode plots in Fig. 7. These plots represent a partially oxidised
and reduced polymer film. It is clear that the impedance changes on
reduction of the polymer, with the impedance increasing. Furthermore,
the impedance changes from a two- to a one-time constant model on
reduction. The open-circuit potential data were fitted to the equivalent
circuit shown in Fig. 7(b), while data recorded at −0.90 V vs SCE were
fitted to the circuit depicted in Fig. 7(c). In these circuits, R1 corre-
sponds to the solution resistance, R2 represents the charge-transfer
resistance, while CPE1 and CPE2 are equivalent to the capacitance of
the polymer and diffusional processes. The computed values of the
circuit elements are summarised in Table 1 for the reduced and partially
oxidised polymer films. The charge-transfer resistance at the open-cir-
cuit-potential was found to increase from an initial value of 370Ω to
400Ω (area of substrate is 0.125 cm2) which was calculated following
300min. The resistance then remained constant indicating good stabi-
lity, conductivity and steady-state conditions. This relatively low re-
sistance is consistent with conducting properties. On reduction of the
polymer film, the resistance increased to 12 kΩ, due to the reduction of
the polymer. However, this resistance is not particularly high and it is
consistent with the mixed ion exchange properties where the con-
ducting polymer, PPy+Dex−, is converted to a mixture of PPyo and
PPyoDex−Na+. As a constant phase element was used to model the
capacitance of the partially oxidised polymer film, it is difficult to ac-
curately estimate the capacitance as the exponent was 0.70 and too far
removed from the ideal value of 1.0 expected for a capacitor. This is
also evident in Fig. 7(a), where the phase angle deviates considerably
from the 90° expected for a capacitor. However, the exponent of the
CPE was 0.5 for the reduced polymer representing a clear diffusional
process and this may be related to the ingress of Na+ cations as the
polymer is reduced.
3.4. Release of Dex from PPyDex and cation exchange
As the published papers describing PPyDex have focussed on the
release of dexamethasone from the polymer matrix, the release of
dexamethasone was studied from these conducting polymer films.
Shown in Fig. 8, are the dexamethasone release studies obtained on
reduction of the polymer at −0.90 V vs SCE for PPyDex formed at
0.90 V vs SCE, and formed at the lower potential of 0.80 V vs SCE using
a two-step process with electropolymerisation of the second layer at
PPyDex or PPyCl. The three polymer systems were deposited to the
same charge of 2.8 C cm−2. It is clear from these data, that the amount
of dexamethasone released depends on how the polymer was formed.
Fig. 4. Frequency-charge plots and mass-charge plots for the deposition of PPyDex in the presence of 0.05mol dm−3 NaDex and 0.20mol dm−3 pyrrole. Inset shows
the charge-time plots for PPyCl.
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Fig. 5. Cyclic voltammograms, 20th cycle, of Pt in 0.05mol dm−3 Dex and
0.10 mol dm−3 NaCl and in 0.10mol dm−3 NaCl (pH=8.2) at a scan rate of
25mV s−1.
Fig. 6. Current coupled with mass change recorded for PPyDex in
0.10 mol dm−3 NaCl, pH 3.0 at a scan rate of 4mV s−1.
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The highest release, corresponding to approximately 200 μg cm−2 after
60 min, was achieved with the PPyDex formed using two steps, with the
PPyDex deposited at 0.80 V vs SCE at the initial PPyDex layer. The
amount of dexamethasone released was reduced to 155 μg cm−2 when
the PPyDex was formed in a single step at 0.90 V vs SCE, and although
this will lead to a more porous and open polymer structure with a
higher surface area, it appears that the polymer formed at these higher
potentials is susceptible to over-oxidation. As the concentration of
dexamethasone is lower in the PPyDex film deposited at the PPyCl
layer, a lower amount was released, showing that the concentration of
dexamethasone is an important parameter even close to the electrode
surface.
The more conducting PPyDex films generated using the two step
approach (formation at 0.90 V and 0.80 V vs SCE in the presence of
dexamethasone) were studied to obtain further information on the re-
lease of the drug. The influence of the applied potential on the release is
summarised in Fig. 9. In general, higher amounts are released as the
applied potential is lowered and the polymer is reduced with more
efficient release achieved at −0.90 V vs SCE. This is in good agreement
with the data presented in Fig. 6, where the reduction wave is seen at
approximately −0.40 V vs Ag|AgCl. The relatively poor release of
dexamethasone observed at −1.0 V vs SCE is probably due to the
competing hydrogen evolution reaction. In addition to consuming
charge, this reaction may also alter the interface between the electrode
and the polymer interface, or lead to local delamination of the polymer,
preventing or inhibiting the reduction of the polymer. However, it is
evident from Fig. 6 that in addition to the release of dexamethasone,
(a)
(b)                                                                                    (c)
Fig. 7. (a) Impedance data recorded at
−0.90 V vs SCE ( ) and at OCP ( )
for PPyDex in 0.1 mol dm−3 NaCl.
Experimental data (_____) and simulated
data (- - - - -) generated using the
equivalent circuits, (b) equivalent cir-
cuit at OCP and (c) equivalent circuit at
−0.90 V vs SCE.
Table 1
Circuit elements obtained on fitting the impedance data obtained after 8 h at
OCP (0.24 V vs SCE) and at −0.90 V vs SCE.
Circuit parameter % Error Potential/V vs SCE
OCP −0.90 V
R2 1.5 400Ω 12,312Ω
CPE1 1.2 3.5× 10−4Ω−1 s−0.7 1.3×10−4Ω−1 s−0.49
CPE1 (exponent) 0.5 0.70 0.49
CPE2 1.7 5.5× 10−3Ω−1 s-0.8 –
CPE2 (exponent) 0.3 0.80 –
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Fig. 8. The amount of Dex measured as a function of time on reducing the
polymer films at −0.90 V vs SCE for ● PPyDex formed at 0.80 V vs SCE at a
PPyDex film, for ○ PPyDex formed at 0.80 V at a PPyCl film and for ■ PPyDex
formed at 0.90 V vs SCE (n=3).
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sodium cations from the solution enter the polymer matrix during this
process. Furthermore, as the uptake of sodium begins at approximately
0.0 V vs Ag/AgCl, Fig. 6, there are no suitable applied potentials that
can be used to release dexamethasone and prevent the incorporation of
sodium into the polymer film.
The amount of dexamethasone available for release was estimated
as 270 ± 8 μg cm−2 by measuring the amount of dexamethasone re-
leased after 10 h at −0.90 V vs SCE. As cations are injected on reduc-
tion of the polymer film not all the incorporated dexamethasone is re-
leased. Assuming that the doping level remains at 0.30 for the bulk
polymer, the amount of dexamethasone incorporated within the poly-
pyrrole films was estimated as 1.9mg cm−2. Although the complete
reduction and release of any drug or dopant is unlikely and the esti-
mated uptake of 1.9 mg cm−2, which is based on EQCM data, does not
take into account solvent participation, there is a significant difference
between the quantities of dexamethasone incorporated and released.
This is consistent with the incorporation of cations during the release of
dexamethasone and as more cations are incorporated more of the
dexamethasone remains within the polymer films.
The possibility of reusing the PPyDex films was studied by re-oxi-
dising the reduced polymer film in the presence of 0.06mol dm−3
dexamethasone at 0.80 V vs SCE. Then the polymers were reduced at
−0.90 V vs SCE and the release of dexamethasone was followed. This
was repeated several times and representative data are shown in
Fig. 10. In this figure, the amount of dexamethasone released following
a 60-min release period is shown as a function of the number of times
the polymer was used and exposed to an oxidation and reduction event.
There is a considerable reduction in the amount of dexamethasone re-
leased on comparing the first and second release experiments. This is
expected as it is well known that there is a loss in the conductivity of
polypyrrole when it is reduced for extended time periods [25]. How-
ever, unexpected results were obtained for the third and fourth release
experiments, which show a gradual and significant increase in the
amount of dexamethasone released. This indicates that the incorpora-
tion or release of dexamethasone becomes increasingly easier as the
polymer is cycled between reduction and oxidation.
This may be related to the presence of sodium within the polymer
matrix. During repeated reduction and oxidation of the polymer it is
possible that higher amounts of sodium are accumulated within the
polymer film and consequently to maintain charge neutrality more
dexamethasone is transferred to the polymer. Latonen et al. [26] in
studying the ion exchange behaviour of polypyrrole doped with large
anions, suggested the formation of ion pairs, this electrostatic interac-
tion between the cation and anion makes it more difficult to expel the
cation on oxidation of the polymer. Indeed, there is evidence in Fig. 6,
that the rate of the sodium cation expulsion is slower than its ingress. It
is also possible that the formation of these ion pairs facilitate the uptake
of higher concentrations of dexamethasone, as illustrated in Eq. (4). In
this analysis the reduced polymer film is represented as containing
some dexamethasone,PPy0. nDex−. nNa+. bH2O. On oxidation, the
sodium is released, but some remains, possibly forming an ion pair with
the dexamethasone. On further oxidation, uptake of dexamethasone
occurs due to the positively charged backbone, however additional
dexamethasone is incorporated to neutralise the positively charged
sodium cation, as illustrated in Eq. (4).
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As more sodium ions are incorporated, some of these ion pairs may
become detached from the polymer backbone and during the sub-
sequent release experiment, they may be released through a diffusion-
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Fig. 9. Amount of Dex released following 60min at various applied potentials
(n=3).
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controlled process giving a further increase in the amount released.
Even though the conductivity of the polymer film may be decreasing on
repeated oxidation and reduction, and this would normally give rise to
a reduction in the release of dexamethasone, the opposing effect be-
comes more significant arising from the cation exchange properties of
the polymer, to give the trend seen in Fig. 10. This high uptake of
dopants, ion pairs and accumulation of salt leads to swelling and de-
swelling of the polymer matrix and structural damage becomes evident.
This is clearly seen in Fig. 10, where the surface of the PPyDex fol-
lowing repeated release and doping steps is shown. The micrograph
indicates the presence of cracks caused by swelling and de-swelling
events. Furthermore, the accompanying EDX spectrum shows evidence
of sodium uptake. The oxygen signal is related to the presence of dex-
amethasone and possibly to the formation of carbonyl groups that arise
from the over-oxidation of polypyrrole which may occur following
these repeated oxidation steps.
4. Conclusions
Polypyrrole doped with dexamethasone was easily deposited onto a
pre-layer of polypyrrole, PPyCl or PPyDex, at relatively low applied
potentials of 0.70 V or 0.80 V vs SCE. The polymers were deposited to
2.8 C cm−2, to give relatively thick polymers, that had a low charge-
transfer resistance of 400Ω (0.125 cm2 Pt surface area). Using EQCM,
the doping level was calculated as 0.30 ± 0.03. The uptake of sodium
was clearly observed for thin polymer films using EQCM. A higher
amount of dexamethasone was released for the more conducting
polymers formed at the lower applied potential, while the rate of re-
lease increased on the application of more electronegative potentials
with the highest rate of release evident at −0.90 V vs SCE. During re-
peated oxidation and reduction of the polymer film, an increasing
amount of dexamethasone was released and this was explained in terms
of the cation exchange properties of the polymer films. It appears that
sodium is accumulated within the polymer matrix. While this gives
higher release rates, the associated swelling and de-swelling of the
polymer film leads to the development of structural damage and cracks
within the polymer matrix. Although it is possible to release relatively
high amounts of dexamethasone on reduction of polypyrrole, this
system will also uptake cations from the release medium and this may
limit its potential as a delivery system for dexamethasone.
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